{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T05:55:51Z","timestamp":1775195751971,"version":"3.50.1"},"reference-count":9,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Institute of Child Health and Human Development Contraception Clinical Trial Network","award":["HHSN275200403378I"],"award-info":[{"award-number":["HHSN275200403378I"]}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health (NIH)","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"OHSU Oregon Clinical & Translational Research Institute","award":["NIH NCRR 1 UL1 RR024120"],"award-info":[{"award-number":["NIH NCRR 1 UL1 RR024120"]}]},{"name":"Endocrine Technologies Support Core at the Oregon National Primate Research Center","award":["NIH P51 OD011092"],"award-info":[{"award-number":["NIH P51 OD011092"]}]}],"content-domain":{"domain":["contraceptionjournal.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.contraception.2016.07.018","type":"journal-article","created":{"date-parts":[[2016,7,28]],"date-time":"2016-07-28T07:13:35Z","timestamp":1469690015000},"page":"55-58","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Levonorgestrel butanoate intramuscular injection does not reliably suppress ovulation for 90 days in obese and normal-BMI women: a pilot study"],"prefix":"10.1016","volume":"95","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5040-7288","authenticated-orcid":false,"given":"Alison B.","family":"Edelman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ganesh","family":"Cherala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francis","family":"Pau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana L.","family":"Blithe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey T.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2016.07.018_bb0005","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0039-128X(83)90095-8","article-title":"Long-acting contraceptive agents: design of the WHO chemical synthesis Programme","volume":"41","author":"Crabbe","year":"1983","journal-title":"Steroids"},{"key":"10.1016\/j.contraception.2016.07.018_bb0010","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1159\/000343067","article-title":"The special programme of research in human reproduction: forty years of activities to achieve reproductive health for all","volume":"74","author":"Benagiano","year":"2012","journal-title":"Gynecol Obstet Investig"},{"key":"10.1016\/j.contraception.2016.07.018_bb0015","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/0960-0760(91)90293-E","article-title":"Long-acting hormonal contraceptives for women","volume":"40","author":"Garza-Flores","year":"1991","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.contraception.2016.07.018_bb0020","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0015-0282(98)00309-4","article-title":"Timing of onset of contraceptive effectiveness in Depo-Provera users. II. Effects on ovarian function","volume":"70","author":"Petta","year":"1998","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2016.07.018_bb0025","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S0015-0282(97)00476-7","article-title":"Timing of onset of contraceptive effectiveness in Norplant implant users. Part I. Changes in cervical mucus","volume":"69","author":"Dunson","year":"1998","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2016.07.018_bb0030","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1365-2141.2007.06780.x","article-title":"Risk of venous thrombosis: obesity and its joint effect with oral contraceptive use and prothrombotic mutations","volume":"139","author":"Pomp","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.contraception.2016.07.018_bb0035","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.contraception.2009.04.011","article-title":"Impact of obesity on oral contraceptive pharmacokinetics and hypothalamic\u2013pituitary\u2013ovarian activity","volume":"80","author":"Edelman","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2016.07.018_bb0040","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.contraception.2012.10.008","article-title":"Prolonged monitoring of ethinyl estradiol and levonorgestrel levels confirms an altered pharmacokinetic profile in obese oral contraceptives users","volume":"87","author":"Edelman","year":"2012","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2016.07.018_bb0045","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.contraception.2010.04.016","article-title":"Metabolism and pharmacokinetics of contraceptive steroids in obese women: a review","volume":"82","author":"Edelman","year":"2010","journal-title":"Contraception"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001078241630172X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001078241630172X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,16]],"date-time":"2018-11-16T04:24:27Z","timestamp":1542342267000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001078241630172X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":9,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S001078241630172X"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2016.07.018","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Levonorgestrel butanoate intramuscular injection does not reliably suppress ovulation for 90 days in obese and normal-BMI women: a pilot study","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2016.07.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}